Filing Manager
GLAZER CAPITAL, LLC
Reporting Manager
Glazer Capital, LLC
Symbol
CKPT
Shares outstanding
83,070,866 shares
Disclosed Ownership
3,165,000 shares
Ownership
3.8%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:13:32 UTC
Date of event
31 Mar 2025
Previous filing
17 Mar 2025

Key filing fact

GLAZER CAPITAL, LLC disclosed 3.8% ownership in CHECKPOINT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (CKPT) on 31 Mar 2025.

Key facts

  • GLAZER CAPITAL, LLC filed SCHEDULE 13G/A for CHECKPOINT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (CKPT).
  • Disclosed ownership: 3.8%.
  • Date of event: 31 Mar 2025.

Change

  • Previous schedule filing date: 17 Mar 2025.
  • Current filing was accepted on 15 May 2025, 16:13.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (2)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Glazer Capital, LLC 3.8% 3,165,000 0 3,165,000 Paul J. Glazer Paul J. Glazer, Managing Member
Paul J. Glazer 3.8% 3,165,000 0 3,165,000 Paul J. Glazer Paul J. Glazer
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .